As in the study reported by Couch and colleagues, no mutations in the CHEK2 and TP53 genes were observed in two Pakistani studies among 374 (including 103 with TNBC) [46] and 105 (including 47 with TNBC) breast/ovarian cancer patients [47], respectively. The gene discussed is TP53; the disease is ovarian cancer.